Literature DB >> 22732922

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.

Jana Blazkova1, Tae-Wook Chun, Bietel W Belay, Danielle Murray, J Shawn Justement, Emily K Funk, Amy Nelson, Claire W Hallahan, Susan Moir, Paul A Wender, Anthony S Fauci.   

Abstract

Persistence of the latent viral reservoir has been recognized as a major obstacle to eradicating human immunodeficiency virus (HIV) in infected individuals receiving antiretroviral therapy. It has been suggested that histone deacetylase inhibitors (HDACis) may purge HIV in the latent viral reservoir. However, the effect of HDACis on the degree and extent of HIV expression in the latent viral reservoir has not been fully delineated. Here we demonstrate that HDACis do not induce HIV production in the latent viral reservoir of aviremic individuals. Therefore, alternative therapeutic strategies may be necessary to eliminate HIV in the latent viral reservoir.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732922      PMCID: PMC3491743          DOI: 10.1093/infdis/jis412

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Re-emergence of HIV after stopping therapy.

Authors:  T W Chun; R T Davey; D Engel; H C Lane; A S Fauci
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

2.  HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

Authors:  Tae-Wook Chun; David C Nickle; J Shawn Justement; Danielle Large; Alice Semerjian; Marcel E Curlin; M Angeline O'Shea; Claire W Hallahan; Marybeth Daucher; Douglas J Ward; Susan Moir; James I Mullins; Colin Kovacs; Anthony S Fauci
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

3.  Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.

Authors:  Nathalie Sagot-Lerolle; Aurelia Lamine; Marie-Laure Chaix; Faroudy Boufassa; Jean-Paul Aboulker; Dominique Costagliola; Cécile Goujard; Coralie Pallier; Coralie Paller; Jean-François Delfraissy; Olivier Lambotte
Journal:  AIDS       Date:  2008-06-19       Impact factor: 4.177

4.  Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

Authors:  Ginger Lehrman; Ian B Hogue; Sarah Palmer; Cheryl Jennings; Celsa A Spina; Ann Wiegand; Alan L Landay; Robert W Coombs; Douglas D Richman; John W Mellors; John M Coffin; Ronald J Bosch; David M Margolis
Journal:  Lancet       Date:  2005 Aug 13-19       Impact factor: 79.321

5.  The survival benefits of AIDS treatment in the United States.

Authors:  Rochelle P Walensky; A David Paltiel; Elena Losina; Lauren M Mercincavage; Bruce R Schackman; Paul E Sax; Milton C Weinstein; Kenneth A Freedberg
Journal:  J Infect Dis       Date:  2006-06-01       Impact factor: 5.226

6.  Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

Authors:  T W Chun; D Engel; S B Mizell; C W Hallahan; M Fischette; S Park; R T Davey; M Dybul; J A Kovacs; J A Metcalf; J M Mican; M M Berrey; L Corey; H C Lane; A S Fauci
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

7.  Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.

Authors:  Janet D Siliciano; Jun Lai; Marc Callender; Eleanor Pitt; Hao Zhang; Joseph B Margolick; Joel E Gallant; Joseph Cofrancesco; Richard D Moore; Stephen J Gange; Robert F Siliciano
Journal:  J Infect Dis       Date:  2007-01-30       Impact factor: 5.226

8.  Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid.

Authors:  Nancie M Archin; Amy Espeseth; Daniel Parker; Manzoor Cheema; Daria Hazuda; David M Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

9.  Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.

Authors:  Paul A Wender; Jung-Min Kee; Jeffrey M Warrington
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

10.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.

Authors:  E L Delwart; E G Shpaer; J Louwagie; F E McCutchan; M Grez; H Rübsamen-Waigmann; J I Mullins
Journal:  Science       Date:  1993-11-19       Impact factor: 47.728

View more
  68 in total

Review 1.  Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.

Authors:  Ariel Halper-Stromberg; Michel C Nussenzweig
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

2.  Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells.

Authors:  Sergey Iordanskiy; Fatah Kashanchi
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02       Impact factor: 2.205

Review 3.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

4.  Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs.

Authors:  Nina C Flerin; Ariola Bardhi; Jian Hua Zheng; Maria Korom; Joy Folkvord; Colin Kovacs; Erika Benko; Ronald Truong; Talia Mota; Elizabeth Connick; R Brad Jones; Rebecca M Lynch; Harris Goldstein
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

Review 5.  Kill: boosting HIV-specific immune responses.

Authors:  Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

6.  HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.

Authors:  John M Murray; John J Zaunders; Kristin L McBride; Yin Xu; Michelle Bailey; Kazuo Suzuki; David A Cooper; Sean Emery; Anthony D Kelleher; Kersten K Koelsch
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

7.  HIV reservoirs as obstacles and opportunities for an HIV cure.

Authors:  Tae-Wook Chun; Susan Moir; Anthony S Fauci
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

8.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

9.  Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.

Authors:  Guochun Jiang; Erica A Mendes; Philipp Kaiser; Sumathi Sankaran-Walters; Yuyang Tang; Mariana G Weber; Greg P Melcher; George R Thompson; Amilcar Tanuri; Luiz F Pianowski; Joseph K Wong; Satya Dandekar
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

10.  HIV infection: what should be considered in approaches for a cure?

Authors:  Jay A Levy; Yves Levy
Journal:  AIDS       Date:  2012-11-13       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.